Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Buttini

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Pharmaceutics|January 21, 2022
In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and ViscosityGustavo Vaz, Adryana Clementino, Evgenia Mitsou, et al.
International Journal of Pharmaceutics|June 9, 2018
Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapyFrancesca Buttini, Anna Giulia Balducci, Gaia Colombo, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 8, 2015
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formationSilvia Belotti, Alessandra Rossi, Paolo Colombo, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal SymptomsEride Quarta, Fabio Sonvico, Ignazio La Mantia, et al.
International Journal of Pharmaceutics|December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIsDavide D'Angelo, Veronica Chierici, Eride Quarta, et al.
International Journal of Pharmaceutics|June 3, 2014
Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product constructionSilvia Belotti, Alessandra Rossi, Paolo Colombo, et al.
International Journal of Pharmaceutics|January 28, 2023
Corrigendum to "No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs" [Int. J. Pharm. 631 (2023) 122478]Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Drug Delivery and Translational Research|April 25, 2023
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsinAnnalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2017
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effectFabio Sonvico, Chiara Conti, Gaia Colombo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2017
Opportunity and challenges of nasal powders: Drug formulation and deliveryLaura Tiozzo Fasiolo, Michele Dario Manniello, Elena Tratta, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Pharmaceutics|January 21, 2022
In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and ViscosityGustavo Vaz, Adryana Clementino, Evgenia Mitsou, et al.
International Journal of Pharmaceutics|June 9, 2018
Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapyFrancesca Buttini, Anna Giulia Balducci, Gaia Colombo, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 8, 2015
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formationSilvia Belotti, Alessandra Rossi, Paolo Colombo, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal SymptomsEride Quarta, Fabio Sonvico, Ignazio La Mantia, et al.
International Journal of Pharmaceutics|December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIsDavide D'Angelo, Veronica Chierici, Eride Quarta, et al.
International Journal of Pharmaceutics|June 3, 2014
Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product constructionSilvia Belotti, Alessandra Rossi, Paolo Colombo, et al.
International Journal of Pharmaceutics|January 28, 2023
Corrigendum to "No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs" [Int. J. Pharm. 631 (2023) 122478]Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Drug Delivery and Translational Research|April 25, 2023
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsinAnnalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2017
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effectFabio Sonvico, Chiara Conti, Gaia Colombo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2017
Opportunity and challenges of nasal powders: Drug formulation and deliveryLaura Tiozzo Fasiolo, Michele Dario Manniello, Elena Tratta, et al.
Pageof 9